Literature DB >> 28546944

Corticosteroid-associated atypical central serous chorioretinopathy in a patient with multiple sclerosis.

Mahmut Kaya1, Derya Kaya2, Egemen Idiman3.   

Abstract

Entities:  

Year:  2017        PMID： 28546944      PMCID： PMC5437475          DOI： 10.18240/ijo.2017.05.27

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  13 in total

1.  Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS.

Authors:  F Sellebjerg; J L Frederiksen; P M Nielsen; J Olesen
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  [Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study].

Authors:  A Ahnoux-Zabsonre; M Quaranta; M Mauget-Faÿsse
Journal:  J Fr Ophtalmol       Date:  2004-12       Impact factor: 0.818

4.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

5.  Systemic findings associated with central serous chorioretinopathy.

Authors:  M K Tittl; R F Spaide; D Wong; E Pilotto; L A Yannuzzi; Y L Fisher; B Freund; D R Guyer; J S Slakter; J A Sorenson
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

6.  Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy.

Authors:  Tarun Sharma; Nitant Shah; Madhav Rao; Lingam Gopal; Mahesh P Shanmugam; Mahesh Gopalakrishnan; Pramod Bhende; Muna Bhende; Nitin S Shetty; Sukumar Baluswamy
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

7.  Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.

Authors:  M Selim Kocabora; Sahan Durmaz; Nilay Kandemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-03       Impact factor: 3.117

8.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

9.  The onset location of multiple sclerosis predicts the location of subsequent relapses.

Authors:  E M Mowry; S Deen; I Malikova; J Pelletier; P Bacchetti; E Waubant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-12-09       Impact factor: 10.154

Review 10.  Multiple sclerosis. Part I: neuro-ophthalmic manifestations.

Authors:  John H Pula; Anthony T Reder
Journal:  Curr Opin Ophthalmol       Date:  2009-11       Impact factor: 3.761
View more
  1 in total

1.  Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.

Authors:  Ge Ge; Yun Zhang; Yichi Zhang; Zhihui Xu; Meixia Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.